Pharmaceuticals Health Insurance Healthcare Companies Insurance Medical Devices Cybersecurity Healthcare Services Biotechnology Legal Issues Technology Biopharmaceuticals Mental Healthcare Clinical Trials Mental Health Conditions Company Performance Pharmaceutical Industry Government Vaccines Private Hospitals Clinical Research Organizations Insurance Sector Medicare Advantage Healthcare Delivery Cost Management Centene Corporation Hospital Operations Oncology Hospital Management Hospitals Medicare Operational Performance Market Trends Insider Transactions Healthcare Stocks Medical Costs Insurance Companies Corporate Strategy InfuSystems Holdings Corporate Restructuring Telecommunications Companies Retail Insider Trading GE Healthcare Motion Sickness Medicare Practices Financial Performance Digital Healthcare
The approval follows late-stage trials showing significant reductions in vomiting versus placebo.
